Deal Search
655 of 655 deals · sorted by realized moic
🛡️ Public data only — no PHI permitted on this instance.
About this page
Full-text search across the 655-deal corpus with filters on sector, vintage year range, EV range, MOIC range, payer regime, and deal type, sortable by any column.
Source: data_public/deal_search.py (corpus query engine).
Results
655
of 655 corpus deals
P50 MOIC
2.80x
filtered set
Avg EV
$2219M
filtered set
Page
5/17
40 per page
Search & Filter
655 Results
| ID | Deal | Buyer | Sector | Year | EV | EV/EBITDA | Hold | MOIC | IRR | Payer | Type |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ext_31_010 | Women's Health | 2018 | $780M | 12.0x | 5.0y | 3.00x | 25.0% | LBO | |||
| ext_005 | — | 2013 | $450M | 8.2x | 3.0y | 2.90x | 41.0% | — | |||
| seed_246 | — | 2019 | $750M | 12.5x | 5.0y | 2.90x | 24.0% | secondary_ | |||
| seed_613 | Healthcare Equipment | 2019 | $1450M | 10.0x | 4.0y | 2.90x | 30.0% | — | |||
| seed_625 | Healthcare Consultin | 2020 | $75M | 8.3x | 3.5y | 2.90x | 36.0% | — | |||
| ext_31_004 | Dermatology | 2017 | $520M | 10.8x | 6.0y | 2.90x | 19.0% | LBO | |||
| ext_31_017 | Gastroenterology | 2020 | $1100M | 11.6x | 4.0y | 2.90x | 30.0% | LBO | |||
| seed_059 | — | 2014 | $475M | 7.7x | 4.0y | 2.80x | 29.0% | — | — | ||
| seed_117 | — | 2019 | $580M | 12.1x | 3.5y | 2.80x | 24.0% | — | |||
| seed_208 | — | 2019 | $1100M | 12.2x | 5.0y | 2.80x | 23.0% | lbo | |||
| seed_214 | — | 2015 | $640M | 11.0x | 6.0y | 2.80x | 18.0% | — | lbo | ||
| seed_244 | — | 2021 | $1300M | — | 4.0y | 2.80x | 30.0% | merger | |||
| seed_262 | — | 2020 | $150M | 12.5x | 5.0y | 2.80x | 23.0% | strategic_ | |||
| seed_341 | home_community_based | 2014 | $1400M | 9.5x | 5.0y | 2.80x | 22.0% | lbo | |||
| seed_359 | physician_group | 2014 | $280M | 9.0x | 5.0y | 2.80x | 22.0% | lbo | |||
| seed_375 | nemt | 2018 | $750M | 9.0x | 4.0y | 2.80x | 22.0% | lbo | |||
| seed_377 | lab | 2015 | $6100M | 14.0x | 5.0y | 2.80x | 20.0% | merger | |||
| seed_400 | population_health | 2015 | $170M | 14.0x | 4.0y | 2.80x | 22.0% | merger | |||
| seed_406 | physical_therapy | 2020 | $180M | 10.0x | 4.0y | 2.80x | 23.0% | add-on | |||
| seed_424 | hospital | 2018 | $4350M | 12.0x | 5.0y | 2.80x | 22.0% | merger | |||
| seed_433 | physician_group | 2014 | $2350M | 14.0x | 4.0y | 2.80x | 22.0% | merger | |||
| seed_446 | managed_care_service | 2017 | $340M | 12.0x | 5.0y | 2.80x | 22.0% | — | carve-out | ||
| seed_449 | pharmacy | 2019 | $3200M | 12.0x | 4.0y | 2.80x | 22.0% | merger | |||
| seed_463 | home_health | 2019 | $1200M | 10.0x | 5.0y | 2.80x | 22.0% | — | |||
| seed_480 | health_it | 2016 | $2200M | 12.6x | 5.0y | 2.80x | 22.0% | — | |||
| seed_500 | radiology | 2021 | $1800M | 12.0x | 3.0y | 2.80x | 39.0% | — | |||
| seed_515 | oncology | 2015 | $580M | 9.7x | 5.0y | 2.80x | 23.0% | — | |||
| seed_537 | behavioral_health | 2018 | $550M | 11.5x | 5.0y | 2.80x | 23.0% | — | |||
| seed_538 | managed_care | 2019 | $2700M | 33.8x | 2.0y | 2.80x | 68.0% | — | |||
| seed_543 | physician_group | 2021 | $2200M | 11.3x | 4.0y | 2.80x | 30.0% | — | |||
| seed_593 | Revenue Cycle Manage | 2016 | $700M | 8.2x | 5.0y | 2.80x | 23.0% | — | |||
| seed_621 | Anesthesiology | 2016 | $950M | 11.6x | 5.0y | 2.80x | 22.0% | — | |||
| ext_31_012 | Orthopedics | 2022 | $180M | 10.0x | 3.0y | 2.80x | 38.0% | LBO | |||
| ext_31_013 | Post-Acute | 2005 | $2100M | 7.5x | 9.0y | 2.80x | 12.0% | Take-priva | |||
| seed_281 | — | 2017 | $1400M | 11.7x | 5.0y | 2.70x | 22.0% | take_priva | |||
| ext_31_020 | Pain Management | 2019 | $240M | 10.0x | 4.0y | 2.70x | 28.0% | LBO | |||
| seed_024 | — | 2010 | $650M | 9.0x | 5.0y | 2.60x | 21.0% | — | |||
| seed_061 | — | 2009 | $1050M | 7.5x | 4.5y | 2.60x | 24.0% | — | — | ||
| seed_328 | home health / commun | 2019 | $1320M | 10.8x | 4.5y | 2.60x | 21.0% | lbo | |||
| seed_336 | ltach_post_acute | 2018 | $4100M | 10.8x | 4.0y | 2.60x | 19.0% | take-priva |